Corrections: levodopa for parkinson’s disease (9 July, page 56)

1990 ◽  
Vol 28 (21) ◽  
pp. 84-84
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Low Dose ◽  
Dose Therapy

The table incorrectly described Sinemet LS and Sinemet Plus, which are both capsules, and Madopar 125 and 62.5, which are both tablets. Reference 14 refers to the study by Lees and Stern described in the paragraph ‘Low Dose Therapy’, and should have been cited there, not later.

scholarly journals Bromocriptine in Parkinson’s Disease: Results Obtained With High and Low Dose Therapy

1984 ◽  
Vol 11 (S1) ◽  
pp. 225-228 ◽  
Author(s):  
J. David Grimes
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Statistical Analysis ◽  
Low Dose ◽  
Response Rate ◽  
De Novo ◽  
High Dose ◽  
High Dose Therapy ◽  
Treatment Groups ◽  
Dose Therapy

ABSTRACTThe results obtained with high and low dose bromocriptine therapy were compared in a review assessing the per cent of patients showing improvement (not taking account of the extent of improvement). It is concluded that the response rate with low dose bromocriptine is as good as that obtained with high dose therapy for both de novo and levodopa treated patients. The incidence of adverse effects is similar in the high and low dose treatment groups: More levodopa reduction results in a higher daily bromocriptine requirement. A statistical analysis of 61 bromocriptine-levodopa treated patients showed no positive correlation between bromocriptine dose and severity or duration of Parkinson’s disease.

Randomized study of sertraline and low-dose amitriptyline in patients with Parkinson's disease and depression: Effect on quality of life

2006 ◽  
Vol 21 (8) ◽  
pp. 1119-1122 ◽  
Author(s):  
Angelo Antonini ◽  
Silvana Tesei ◽  
Anna Zecchinelli ◽  
Paolo Barone ◽  
Danilo De Gaspari ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Low Dose ◽  
Randomized Study ◽  
Depression Effect

Investigation of tyrosine hydroxylase and BDNF in a low-dose rotenone model of Parkinson's disease

2015 ◽  
Vol 70 ◽  
pp. 33-41 ◽  
Author(s):  
Michaela E. Johnson ◽  
Yoon Lim ◽  
Manjula Senthilkumaran ◽  
Xin-Fu Zhou ◽  
Larisa Bobrovskaya
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Tyrosine Hydroxylase ◽  
Low Dose

Characterization of a new low-dose 6-hydroxydopamine model of Parkinson's disease in rat

2016 ◽  
Vol 94 (4) ◽  
pp. 318-328 ◽  
Author(s):  
Anna-Maija Penttinen ◽  
Ilida Suleymanova ◽  
Katrina Albert ◽  
Jenni Anttila ◽  
Merja H. Voutilainen ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Low Dose ◽  
6 Hydroxydopamine

High-dose therapy with ropinirole in patients with Parkinson's disease

2001 ◽  
Vol 108 (11) ◽  
pp. 1309-1317 ◽  
Author(s):  
M. M�ngersdorf ◽  
U. Sommer ◽  
M. Sommer ◽  
H. Reichmann
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
High Dose ◽  
High Dose Therapy ◽  
Dose Therapy

Low-dose clozapine improves dyskinesias in Parkinson's disease

Neurology ◽  
1997 ◽  
Vol 48 (3) ◽  
pp. 658-662 ◽  
Author(s):  
F. Durif ◽  
M. Vidailhet ◽  
F. Assal ◽  
C. Roche ◽  
A. M. Bonnet ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Low Dose
Sign in / Sign up

Export Citation Format

Share Document